Case Study: a translational research company accelerates immune disorder target discovery with Elucidata

a translational research company accelerates target discovery with Elucidata and 5M harmonized cells

The customer, a translational research company based in South San Francisco, faced challenges in finding high-quality, well-annotated public datasets for their work in inflammatory diseases. They struggled with annotating cell types and integrating the low-quality data into their internal infrastructure. The vendor, Elucidata, was engaged to address these issues using its services and platform.

Elucidata delivered high-quality, ML-ready public datasets comprising 5 million cells and 11,000 multi-modal samples, which were fully annotated and integrated via APIs. This solution saved the customer approximately 1600 hours of work, significantly expediting their research goals in target discovery for immune-mediated disorders.

Translational Research Company